Circulating Tumor Cells Market: Revenue Growth and Future Projections
Global Circulating Tumor Cells Market to Surpass $31 Billion by 2032, Fueled by Rising Cancer Prevalence and Liquid Biopsy Advancements
The global Circulating Tumor Cells (CTC) Market is experiencing robust growth as a critical frontier in the fight against cancer. Valued at $13.06 billion in 2024, the market is projected to expand at a compelling compound annual growth rate of 11.7%, reaching nearly $31.67 billion by 2032. This powerful growth is driven by the urgent global need for better cancer diagnostics, the rise of personalized medicine, and the